PARDD Poniard Pharmaceuticals, Inc. (MM)

2.95

0.00 (0.00%)

Last Updated: 01:00:00

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Poniard Pharmaceuticals, Inc. (MM)	NASDAQ:PARDD	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	2.95						0	01:00:00

Poniard Pharmaceuticals and Allozyne Terminate Planned Merger

22/12/2011 1:00pm

Marketwired

Poniard Pharmaceuticals, Inc. (MM) (NASDAQ:PARDD)
Historical Stock Chart

From Jul 2019 to Jul 2024

Click Here for more Poniard Pharmaceuticals, Inc. (MM) Charts.

Poniard Pharmaceuticals, Inc. (NASDAQ: PARDD) today announced that Poniard and Allozyne, Inc. have mutually agreed to terminate the Agreement and Plan of Merger and Reorganization dated June 22, 2011. The termination follows the parties' determination that the common stock of the combined company resulting from the proposed merger will not qualify for listing on The Nasdaq Capital Market, which is a condition to closing of the merger. Poniard's board of directors is actively exploring alternatives for Poniard's business and assets.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit http://www.poniard.com.

For Further Information: Media: David Pitts Argot Partners (212) 600-1902 Email Contact